Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Norihito, Soga"'
Autor:
Takumi Kageyama, Norihito Soga, Sho Sekito, Seiichi Kato, Yuji Ogura, Takahiro Kojima, Masahiro Kanai, Takahiro Inoue
Publikováno v:
IJU Case Reports, Vol 5, Iss 6, Pp 442-445 (2022)
Introduction Prostate cancer with a microsatellite instability‐high or mismatch repair‐deficient status is not common. Few reports of the response to pembrolizumab in metastatic castration‐resistant prostate cancer in a real‐world setting hav
Externí odkaz:
https://doaj.org/article/cb69f5de177c464caf96744c9bc949b8
Autor:
Mikiya Ishihara, Shinichi Kageyama, Yoshihiro Miyahara, Takeshi Ishikawa, Shugo Ueda, Norihito Soga, Hiroaki Naota, Katsumi Mukai, Naozumi Harada, Hiroaki Ikeda, Hiroshi Shiku
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Cancer testis (CT) antigens are promising targets for cancer immunotherapies such as cancer vaccines and genetically modified adoptive T cell therapy. In this study, we evaluated the expression of three CT antigens, melanoma-assoc
Externí odkaz:
https://doaj.org/article/20436dffba2045e08c3308ed02b352e7
Autor:
Yutaka Kondo, Satoru Takahashi, Norihito Soga, Aya Naiki-Ito, Shugo Suzuki, Fumiharu Ohka, Akira Hatanaka, Keiko Shinjo, Keisuke Katsushima, Shinya Sato
Legends for supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a600f5ba45a929b43ff1246b11b8ca3f
https://doi.org/10.1158/0008-5472.22410746
https://doi.org/10.1158/0008-5472.22410746
Autor:
Yutaka Kondo, Satoru Takahashi, Norihito Soga, Aya Naiki-Ito, Shugo Suzuki, Fumiharu Ohka, Akira Hatanaka, Keiko Shinjo, Keisuke Katsushima, Shinya Sato
Targeting androgen receptor (AR) by pharmacologic intervention is one of the effective approaches for treatment of malignant prostate cancers. Histone deacetylase (HDAC) alters the epigenetic status of tumor-associated genes, including those for miRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21933ae855c279a1466317bba0818926
https://doi.org/10.1158/0008-5472.c.6508058.v1
https://doi.org/10.1158/0008-5472.c.6508058.v1
Autor:
Yutaka Kondo, Satoru Takahashi, Norihito Soga, Aya Naiki-Ito, Shugo Suzuki, Fumiharu Ohka, Akira Hatanaka, Keiko Shinjo, Keisuke Katsushima, Shinya Sato
Supplementary Table S1. Background of Prostate Cancer Patients. Supplementary Table S2. List of the primers. Supplementary Table S3. 91 miRNAs upregulated in at least 1 of 3 cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a50dca1ea3f3670313f7b6239b68ac1
https://doi.org/10.1158/0008-5472.22410737.v1
https://doi.org/10.1158/0008-5472.22410737.v1
Autor:
Yutaka Kondo, Satoru Takahashi, Norihito Soga, Aya Naiki-Ito, Shugo Suzuki, Fumiharu Ohka, Akira Hatanaka, Keiko Shinjo, Keisuke Katsushima, Shinya Sato
Supplementary Fig. S1. Effect of OBP-801 and other HDAC inhibitors in prostate cancer cells. Supplementary Fig. S2. Western blot analysis of prostate cancer cells treated with OBP-801 or other HDAC inhibitors. Supplementary Fig. S3. Expression analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27945bca30ed99d65a92831106f05546
https://doi.org/10.1158/0008-5472.22410743
https://doi.org/10.1158/0008-5472.22410743
Autor:
Yutaka Kondo, Satoru Takahashi, Norihito Soga, Aya Naiki-Ito, Shugo Suzuki, Fumiharu Ohka, Akira Hatanaka, Keiko Shinjo, Keisuke Katsushima, Shinya Sato
Additional information of Materials and Methods.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d681499475debf77f0c37b9722afdd2
https://doi.org/10.1158/0008-5472.22410740
https://doi.org/10.1158/0008-5472.22410740
Autor:
Naozumi Harada, Katsunori Uchida, Takeshi Sasaki, Yoshiki Sugimura, Yasutaka Tono, Gill A Webster, Naoyuki Katayama, Shinichi Kageyama, Hiroshi Shiku, Toshiro Mizuno, Yoshihiro Miyahara, Hideki Kanda, Mikiya Ishihara, Eiichi Sato, Taizo Shiraishi, Yasuhide Hori, Norihito Soga, Hiroaki Ikeda, Daisuke Muraoka
Publikováno v:
Cancer Immunology, Immunotherapy
Cholesteryl pullulan (CHP) is a novel antigen delivery system. CHP and New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen complexes (CHP-NY-ESO-1) present multiple epitope peptides to the MHC class I and II pathways. Adjuvants are essen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3477f6e7567b8e1a8173e128b6e3de91
http://europepmc.org/articles/PMC7113205
http://europepmc.org/articles/PMC7113205
Publikováno v:
Cancer Diagn Progn
Background/Aim: We investigated pre-operative factors for predicting whether renal masses are benign in order to facilitate the selection of optimal candidates for pre-operative biopsy. Patients and Methods: We evaluated 278 patients with renal masse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::813e4a97dd2c2c8471a8ebd5e7a94fa5
https://pubmed.ncbi.nlm.nih.gov/35530651
https://pubmed.ncbi.nlm.nih.gov/35530651
Publikováno v:
Current Urology. 13:74-81
INTRODUCTION: Near-infrared fluorescence imaging with indocyanine green is a useful tool during partial nephrectomy. Because an accurate method for judging hasn't been established yet, the success rate may be slightly different and inconsistent. MATE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76458284addb2ee9818389196046b795
https://doi.org/10.1159/000499289
https://doi.org/10.1159/000499289